CU20110025A7 - SMAC PEPTIDOMYMETICS USEFUL AS INHIBITORS OF APOPTOSIS PROTEINS (IAP) - Google Patents
SMAC PEPTIDOMYMETICS USEFUL AS INHIBITORS OF APOPTOSIS PROTEINS (IAP)Info
- Publication number
- CU20110025A7 CU20110025A7 CU20110025A CU20110025A CU20110025A7 CU 20110025 A7 CU20110025 A7 CU 20110025A7 CU 20110025 A CU20110025 A CU 20110025A CU 20110025 A CU20110025 A CU 20110025A CU 20110025 A7 CU20110025 A7 CU 20110025A7
- Authority
- CU
- Cuba
- Prior art keywords
- useful
- peptidomymetics
- smac
- iap
- inhibitors
- Prior art date
Links
- 101150082208 DIABLO gene Proteins 0.000 title 1
- 102100033189 Diablo IAP-binding mitochondrial protein Human genes 0.000 title 1
- 230000006907 apoptotic process Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un compuesto de la fórmula (I); o sales farmacéuticamente aceptables del mismo útiles para el tratamiento de enfermedades proliferativas, tales como cáncer, en mamíferos. ESPACIO PARA LA FÓRMULAThe present invention relates to a compound of the formula (I); or pharmaceutically acceptable salts thereof useful for the treatment of proliferative diseases, such as cancer, in mammals. FORMULA SPACE
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20110025A CU20110025A7 (en) | 2011-02-02 | 2011-02-02 | SMAC PEPTIDOMYMETICS USEFUL AS INHIBITORS OF APOPTOSIS PROTEINS (IAP) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20110025A CU20110025A7 (en) | 2011-02-02 | 2011-02-02 | SMAC PEPTIDOMYMETICS USEFUL AS INHIBITORS OF APOPTOSIS PROTEINS (IAP) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20110025A7 true CU20110025A7 (en) | 2011-12-28 |
Family
ID=45508735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20110025A CU20110025A7 (en) | 2011-02-02 | 2011-02-02 | SMAC PEPTIDOMYMETICS USEFUL AS INHIBITORS OF APOPTOSIS PROTEINS (IAP) |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20110025A7 (en) |
-
2011
- 2011-02-02 CU CU20110025A patent/CU20110025A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20110027A7 (en) | SMAC PEPTIDOMYMETICS USEFUL AS INHIBITORS OF APOPTOSIS PROTEINS (IAP) | |
| GT201500051A (en) | GLUCOSILCERAMIDE SINTASA INHIBITORS | |
| CR20150078A (en) | 1,4-DISPOSED PIRIDAZINE ANALOGS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO THE DEFICIENCY OF SMN | |
| PY1212975A (en) | Azabicle or quinuclidine-carbamate compounds as glucosylceramide synthase inhibitors | |
| ECSP17073191A (en) | HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS | |
| AR091837A1 (en) | COMPOUNDS FOR DIRECTED IMMUNOTHERAPY | |
| MX374424B (en) | METHODS TO IMPROVE THE SAFETY OF BLOOD-BRAIN BARRIER TRANSPORT. | |
| MX2015012427A (en) | COMPOUNDS OF HETEROARILO ACID MORFOLINONA AS MDM2 INHIBITORS FOR CANCER TREATMENT. | |
| CR20120659A (en) | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT | |
| CU24335B1 (en) | PIRIDOPIRIMIDINAS REPLACED AS INHIBITORS OF THE MEK KINASE AND USEFUL FOR THE TREATMENT OF CANCER | |
| CO6480975A2 (en) | SMAC MIMETICO | |
| UY34960A (en) | DIHYDROPIRIDONE P1 AS INHIBITORS OF THE XIA FACTOR | |
| MX2015006039A (en) | DERIVATIVES OF PIRIMIDIN-2, 4-DIAMINE FOR CANCER TREATMENT. | |
| MX2016001304A (en) | SYK POLYMORPH INHIBITORS. | |
| MX361370B (en) | Dihydropyridone p1 as factor xia inhibitors. | |
| MX2012013206A (en) | Fused bicyclic kinase inhibitors. | |
| ES2570976T3 (en) | Condensed bicyclic 2,4-diaminopyrimidine derivative as dual inhibitor of ALK and FAK | |
| EA201491149A1 (en) | PYRAZOLOPIRIDINE DERIVATIVES, METHODS OF THEIR PRODUCTION AND THEIR THERAPEUTIC USE | |
| ECSP14013179A (en) | INHIBITOR COMPOUND OF THE SIGNALING OF THE NOTCH TRAJECTORY | |
| WO2012104823A3 (en) | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases | |
| CR20150325A (en) | TRICYCLE COMPOUNDS TO INHIBIT THE CFTR CHANNEL | |
| CR20160227A (en) | NEW COMPOUND FOR THE TREATMENT OF SEVERE HYPOGLYCEMIA | |
| ECSP16024798A (en) | NEW COMPOUND FOR THE TREATMENT OF SEVERE HYPOGLYCEMIA | |
| ECSP16024805A (en) | NEW COMPOUND FOR THE TREATMENT OF SEVERE HYPOGLYCEMIA | |
| EA201401045A1 (en) | CONNECTIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ISCHEMIA-REPERFUSION |